Previous Article | Next Article ![]()
Journal of Bacteriology, February 2007, p. 706-716, Vol. 189, No. 3
0021-9193/07/$08.00+0 doi:10.1128/JB.01334-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Department of Biochemistry and Biomedical Sciences, McMaster University, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada,1 Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-05402
Received 22 August 2006/ Accepted 13 November 2006
|
|
|---|
|
|
|---|
Chaperones and proteases perform antagonistic functions, but also often work together, as demonstrated by the Clp protein family in which the peptidase ClpP acts together with the chaperone ClpA or ClpX (5, 9, 16). DegP has the unusual property of working as a chaperone below 28°C but efficiently degrading unfolded proteins above 28°C. Thus, DegP is an example of both chaperone and protease functions combined in the same protein (23). Also, unlike other chaperones and proteases whose activities usually require expenditure of ATP, these activities are carried out in the absence of metabolic energy in DegP (10, 23).
The mature DegP monomer (48 kDa) contains a trypsin-like protease domain at the N terminus, followed by two PDZ domains (11). PDZ domains are modular interaction domains involved in protein targeting and protein complex assembly that bind preferentially to the C-terminal three to four residues of their target protein. The structure of DegP determined by X-ray crystallography (Protein Data Bank [PDB] identification no. 1KY9) (11) shows how the DegP monomers associate into a hexameric "cage," best described as a staggered dimer of trimers (15). Each trimer is stabilized by residues of the protease domain and has a funnel-like shape such that the protease domains form the top of the funnel and the PDZ domains extend away much like a "molecular jellyfish" (3). In the hexamer, the six protease domains form the top and bottom of the cage with the LA loops (11) of opposing trimers wound around each other, forming three spacing pillars that delimitate the side entrances to the chamber. In the "closed" conformation observed in the crystal structure, the PDZ domains cover these entrances, but they protrude away from the protease domain in the "open" conformation, leaving the gates open. The classical Asp-His-Ser catalytic triad of trypsin-like proteases is contained in each monomer within the DegP cage. The LA loop from each DegP monomer protrudes into the active site of the opposite monomer, where it interacts with the L1 and L2 loops (18), blocking access to the catalytic site. Moreover, the L2 loop is twisted in a particular conformation such that it prevents the formation of the oxyanion hole and blocks the S1 specificity pocket, thus rendering the protease inactive (11). The nature of the conformational switch that transforms DegP into a proteolytically active enzyme still remains to be elucidated.
In the cytoplasm, the active sites of major proteases such as the proteasome or the Clp proteins are also sequestered inside self-compartmentalized structures, providing a common mechanism to prevent indiscriminate proteolysis (1, 6). In these cytoplasmic proteases, the mechanism of translocation and proteolysis of substrates inside the digestion chamber is relatively well understood. Since DegP is similar to other self-compartmentalized proteases, it has been postulated that unfolded substrates are delivered through the side entrances into the interior of the cage, where the catalytic sites are located. However, in DegP this process is poorly characterized and experimental evidence showing that substrates are channeled into the chamber for either proteolysis or refolding have yet to become available.
To study whether an enclosed cavity is required in DegP for protease and molecular chaperone activities, we engineered several deletion mutants of DegP to disrupt the DegP hexamer into two trimers. An enclosed cavity no longer exists in these mutants. Additionally, we looked into the consequences of significantly reducing the dimensions of the DegP cage. We found that neither a cage of specific dimensions nor the presence of an enclosed cavity is essential for the chaperone or protease activities in DegP. Furthermore, we determined that residues 39 to 78 within the LA loops, as well as the PDZ2 domains, are essential to maintain the integrity of the DegP hexamer. The implications of these results towards a model of DegP acting as a self-compartmentalized protease are discussed.
|
|
|---|
PDZ2 DegP
mutant was generated by PCR using pET21b-DegP plasmid as the template,
and it was subcloned into the expression vector pET21b. To obtain the
PDZ1 DegP mutant, NheI and SpeI restriction sites were
engineered between residues 262 and 263 and 366 and 367, respectively,
by QuikChange. The plasmid was digested with NheI and SpeI and purified
from the PDZ1 NheI and SpeI fragment by agarose gel electrophoresis and
extraction using the QIAEX II kit (QIAGEN). The plasmid was then
ligated with T4 DNA ligase (Invitrogen), and the six remaining
nucleotides were removed by QuikChange. Proteolytically inactive S210A
variants of the wild type and all DegP mutants were constructed by
QuikChange.
Protein expression and purification.
To express
wild-type DegP, the cage, and the
PDZ domain mutants as
C-terminal His tag proteins, the expression vector pET21b containing
the wild-type or mutant DegP was transformed into E. coli BL21
(DE3) competent cells. The cells were grown in LB medium at
37°C to an optical density at 600 nm (OD600) of 0.7,
and expression was induced with 1 mM IPTG
(isopropyl-ß-D-thiogalactopyranoside). Cells were
induced for 30 min at 37°C or 3 h at 37°C
(S210A DegP mutants). Lysis was performed in 20 ml lysis buffer (50 mM
HEPES, pH 7.3, 10% [wt/vol] sucrose, 0.1 M NaCl, 0.149 M ammonium
sulfate) by addition of 256 µl of lysozyme (50 mg/ml) and
incubation for 3 min at 37°C, followed by sonication on ice.
Lysate was cleared by centrifugation at 39,000 x g for
40 min. NaCl was added to bring the concentration to 1 M, and the
lysate was filtered with a 0.45-µm filter and added to a HiTrap
metal chelating column (GE Healthcare Life Sciences) equilibrated with
50 mM HEPES, pH 7.3, 1 M NaCl, 5% (vol/vol) glycerol. Unspecifically
bound proteins were washed with increasing concentrations of imidazole
up to 90 mM. DegP and its mutants were eluted with 240 mM imidazole.
Purity of the fractions was monitored by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Fractions
containing pure protein were dialyzed against 50 mM HEPES, pH 7.3, in
three steps and stored at
4°C.
Size exclusion chromatography. Gel filtration chromatography was performed on a Superdex 200 10/300 GL column (GE Healthcare Life Sciences) equilibrated in 50 mM HEPES, pH 7.3, containing 100 mM NaCl at 4°C. Protein samples (100 µl) were preincubated at either 4°C, 37°C, or 43°C and applied to the column at concentrations ranging between 0.2 and 3.2 mg/ml at a flow rate of 0.5 ml/min. A gel filtration calibration kit (HMW; GE Healthcare Life Sciences) was used for column calibration.
Analytical centrifugation.
Sedimentation equilibrium experiments
were conducted at 4°C on a Beckman Optima XL-A analytical
ultracentrifuge. Samples (loading volume of 130 µl) were
studied at three loading concentrations, corresponding to
A280 of approximately 0.3, 0.6, and 0.9 (Table
1), and rotor speeds of 4, 6, 8, and 10 krpm. Data were acquired as an
average of four absorbance measurements at a wavelength of 280 nm using
a radial spacing of 0.001 cm. Sedimentation equilibrium was achieved
within 48 h. Data collected at different speeds and different
loading concentrations were analyzed globally in terms of various
species analysis models using SEDPHAT 4.0 (P. S. Schuck;
http://www.analyticalultracentrifugation.com/sedphat/sedphat.htm)
to obtain sample molecular masses. Solution densities,
, were
measured at 20°C on a Mettler-Toledo DE51 density meter and
corrected to values for
at 4°C. Values of the partial
specific volume, v, were calculated based on the amino acid
composition using SEDNTERP (J. Philo;
http://www.jphilo.mailway.com/).
|
View this table: [in a new window] |
TABLE 1. Properties
of DegP mutants studied by analytical
ultracentrifugationa
|
= 280 nm) of about 1.0. One hundred to 125 scans were acquired
at the appropriate rotor speed (35 to 45 krpm) as a single absorbance
measurement at a radial spacing of 0.003 cm using the shortest time
delay possible by setting the time interval to zero. Data were analyzed
in SEDFIT (21)
(P. S. Schuck;
http://www.analyticalultracentrifugation.com/default.htm)
to obtain a sedimentation coefficient distribution in the form of
c(s). All sedimentation coefficients
represent those determined at 4°C in 50 mM HEPES (pH
7.3). Chaperone activity assay. An ammonium sulfate suspension of citrate synthase (CS) (Roche) was dialyzed at 4°C overnight into TE buffer (50 mM Tris-HCl, pH 8, 2 mM EDTA) and concentrated up to 17 mg/ml using nanosep 30K Omega microconcentrators (Pall Corporation). Preparation of chemically denatured CS was done by dilution in a stock of 6 M guanidinium chloride, 50 mM Tris-HCl, pH 8, and 20 mM dithioerythritol for 2 h at room temperature as previously described (2). DegPS210A protein or the mutant DegP proteins were mixed with a 0.15 µM solution of denatured CS in refolding buffer (40 mM HEPES, pH 7.5) at a molar ratio of 4:1 (DegP monomer to CS monomer) and incubated at room temperature with constant stirring. The volume of the refolding reaction was 200 µl. At specific time points, 20-µl samples were extracted from the refolding reaction and the specific activity of CS was measured using an assay based on the first step of the citric acid cycle. The highest specific activity value obtained for DegPS210A was considered as 100% specific activity, and the calculated specific activity of the mutants was expressed as a percentage of this value. The calculation of the specific activity of CS at a given time point of the reaction was done as previously described (2). In brief, the coenzyme A formed in this assay stoichiometrically reduces the Ellman's reagent dithio-1,4-nitrobenzoic acid (DTNB), resulting in an increased absorbance at 412 nm.
Protease activity assays. Reaction mixtures were assembled in 250 µl containing 240 µg of malate dehydrogenase (MDH) from porcine heart (Roche and Sigma), 480 µg of bovine milk ß-casein (Sigma) or 16 µg of egg white lysozyme (Bioshop) in 50 mM HEPES, pH 7.3. Wild-type DegP or the indicated DegP mutant was added to obtain a molar ratio of 1:16 (DegP monomer to substrate). Reaction mixtures were incubated at 37°C for the ß-casein (10) and lysozyme assays and at 43°C for the MDH experiments (10). Dithiothreitol was added to the lysozyme reaction mixtures up to a final concentration of 1.5 mM (22).
At the indicated times, 20-µl samples were taken and mixed with 2x concentrated SDS-PAGE loading buffer. We resolved 14.5 µl, 12.5 µl, and 12.4 µl of each sample of the MDH, ß-casein, and lysozyme reactions, respectively, by SDS-PAGE. Gels were stained according to the manufacturer's protocols with either Coomassie brilliant blue (GE Healthcare Life Sciences) (MDH and ß-casein) or Deep Purple total protein stain (GE Healthcare Life Sciences) (lysozyme). Proteolysis reactions for each specific mutant and substrate were run in the same gel together with an analogous reaction performed with the wild-type DegP. Only the time points of samples that contained an amount of substrate within the linear range for the stain were taken into consideration for the plots.
Coomassie brilliant blue gels were scanned in a flatbed scanner (HP Scanjet 5400c) and Deep Purple-stained gels were scanned in a Typhoon 9200 scanner (GE Healthcare Life Sciences). Data were analyzed with ImageQuant TL software according to manufacturer's protocols, and a proteolysis curve was calculated for each mutant and wild-type DegP protein. The rate of substrate proteolysis observed for each specific mutant was measured by obtaining the ratio between the slope of the proteolysis curve for the mutant and the wild-type DegP protein. Each proteolysis assay was repeated three times, and an average and standard deviation of the ratios were calculated.
|
|
|---|
34-37
plus
80-83) (Fig.
1A, residues in dark
blue). In this reduced cage mutant, the pillar length is partially
reduced and thus is the size of the cavity. A second mutant was
constructed by reducing the length of the pillars even further
(
34-39 plus
60-83) (Fig.
1A, residues in dark blue
and red), thus causing the two trimers to collapse together, maximally
reducing the size of the DegP cavity. This mutant was named the
collapsed cage mutant.
![]() View larger version (52K): [in a new window] |
FIG. 1. Deletions
in the reduced, collapsed, and broken cage DegP mutants. Shown is a
ribbon representation of the open conformation (side view) of the DegP
hexamer (PDB identification no. 1KY9) with opposite subunits of the
hexamer displayed in the same color (green, pink, and orange).
(A) Residues from the LA loop removed in the reduced cage
mutant (34 to 37 plus 80 to 83) are shown in dark blue. In the
collapsed cage mutant, the residues displayed in dark blue and red (34
to 39 plus 60 to 83) were deleted. (B) LA loops after winding
around each other reach the opposite ceiling in the cage and interact
with the DegP subunit at the other end. Residues from this area of the
LA loops shown in dark blue were removed in the broken cage DegP mutant
(39 to 78). Disordered residues (51 to 79) are shown as a dashed
line.
|
![]() View larger version (46K): [in a new window] |
FIG. 2. Oligomeric
state of reduced and collapsed cage DegP mutants. (A) Elution
profile of the reduced and collapsed cage DegP mutants from a
Superdex-200 column after incubation at 4°C for 1 h.
Elution profiles for the proteolytically inactive variants of these
mutants (S210A) and DegPS210A are also displayed. The dashed
lines in the plot on the right-hand side indicate the expected elution
volume for the hexameric (11.5 ml) and the trimeric (13 ml) forms of
these mutants. (B) Samples were withdrawn from the two
fractions of the highest peak on each elution profile and
resolved by SDS-PAGE (15%) and stained with Coomassie brilliant blue.
(C) Sedimentation velocity results for the collapsed cage
DegPS210A and DegPS210A mutants. The
c(s) distributions were obtained using the program
SEDFIT. Peaks corresponding to the hexameric (hx) and dodecameric (dc)
forms are indicated. (D) Sedimentation equilibrium profiles
shown in terms of A280 versus the radius,
r, for samples DegPS210A (left) and the collapsed
cage DegPS210A mutant (right) at loading
A280 of 0.69 and 0.40, respectively. Data collected
at 4 (blue), 6 (green), and 8 (red) krpm at 4.0°C are shown.
Best fits are shown as solid lines, and the corresponding distributions
of the residuals are shown above the
plot.
|
|
View this table: [in a new window] |
TABLE 2. Sedimentation
equilibrium results for DegPS210A, the cage, and
PDZ2 DegPS210A mutants
|
![]() View larger version (22K): [in a new window] |
FIG. 3. Chaperone
and protease activity of the reduced and collapsed DegP mutants.
(A) Chemically denatured citrate synthase was refolded in the
absence of any protein or in the presence of a fourfold molar
excess of BSA, reduced, or collapsed cage
DegPS210A mutants. Citrate synthase activity was measured at
the indicated points and is given as a percentageof the highest specific activity value obtained
for DegPS210A.
DCS, denatured citrate synthase. (B to D) Proteolysis curves of MDH (B,
left plots), ß-casein (C, left plots), and lysozyme (D, left
plots) in the presence of reduced or collapsed cage DegP mutants.
Proteolysis reactions were performed, and samples were resolved by
SDS-PAGE. Gels were stained by Coomassie brilliant blue in the MDH and
ß-casein (B and C) experiments or Deep Purple total protein
stain in the lysozyme assays (D). Gels were scanned, and the substrate
bands were quantified to obtain the hydrolysis curves. The rate of
substrate hydrolysis by a specific mutant is shown as the ratio between
the slope (slp) of the proteolysis curve for the mutant (solid line)
and the wild-type (WT; dashed line) DegP protein. One representative
proteolysis plot from each reaction type is shown. Each experiment was
performed three times, and an average and standard deviation of the
ratio of the rates (mutant to wild type) was calculated for each
reaction type (B, C, and D, right plots). AU, arbitrary units.
|
These data suggest that DegP does not require a cage of specific dimensions to perform either protease or chaperone activity.
Residues from positions 39 to 78 within the LA loops as well as the PDZ2 domains are essential to maintain the DegP hexameric cage. Based on the crystal structure of the DegP open conformation, it has been predicted that interactions between the LA loops of opposite monomers in the cage are mainly responsible for the stability of the hexamer (Fig. 1B). Furthermore, in the closed conformation of the cage, the PDZ2 domain of each monomer interacts with the PDZ1 and PDZ2 domains of the monomer at the opposite trimer in a zipper-like arrangement (11).
To determine
which of these interactions are essential to maintain the integrity of
the hexameric cage, we constructed three deletion mutants: the broken
cage DegP (
39-78) (Fig.
1B),
PDZ1 DegP
(
263-366), and
PDZ2 DegP
(
356-446) mutants. We studied their oligomeric
structure by size exclusion chromatography and sedimentation
experiments.
An injection of purified broken cage DegP mutant in the size exclusion column produced an elution profile with two peaks at the expected elution volume for a trimer and a monomer, respectively (Fig. 4A and B). The proteolytically inactive variant of this mutant (broken cage DegPS210A) also eluted as a trimer and as a monomer. A third peak was also present in the elution profile with the elution volume corresponding to a dodecamer. This peak represents approximately 14% of the total protein (Fig. 4A). The elution profiles of these two mutants were virtually identical upon incubation at either 37°C or 43°C for 1 h before injection into the size exclusion column (data not shown).
![]() View larger version (24K): [in a new window] |
FIG. 4. Oligomeric
state of the broken cage DegP mutant by size exclusion chromatography.
(A) Elution profile of the broken cage DegP mutant and its
proteolytically inactive variant (broken cage DegPS210A)
from a Superdex-200 column after incubation at 4°C for
1 h. The panel on the left shows the elution profile for the
DegPS210A mutant used as a control. The dashed lines in the
plot on the right-hand side indicate the expected elution volume (Ve)
for dodecameric (10.1 ml), hexameric (11.7 ml), trimeric (13.2 ml), and
monomeric (15.5 ml) forms of these mutants. (B) One sample
from each peak was withdrawn, resolved by SDS-PAGE (15%
polyacrylamide), and stained with Coomassie brilliant blue. The lane
number on the gels indicates from which peak the fraction was taken.
(C) Sedimentation equilibrium profiles shown in terms of
A280 versus the radius, r, for the broken
cage DegPS210A mutant at a loading A280
of 0.54. Data were collected at 6 (blue), 8 (green), and 10 (red) krpm
at 4.0°C and analyzed in
terms of
three noninteracting solutes. Best fits are shown as lines through the
experimental points, and the corresponding distributions of
the residuals are shown above the plot. (D) Sedimentation velocity
results for the broken cage DegPS210A showing the
c(s) distributions using
SEDFIT.
|
The c(s) profile of the broken cage DegPS210A mutant obtained by sedimentation velocity showed two well-resolved sedimenting species having sedimentation coefficients of approximately 1.8S and 2.8S (Fig. 4D), which correspond to monomers and trimers, respectively. No evidence for dodecamers was found in these experiments.
These experiments showed that both the broken cage DegP mutant and its proteolytically inactive variant are mostly trimers and monomers, indicating that residues 39 to 78 in DegP are essential to maintain the protein in the hexameric state.
The oligomeric state of the
PDZ1
and
PDZ2 DegP mutants and their S210A variants was also
investigated by size exclusion chromatography. After 1 h of
incubation of the mutants at either 4°C, 37°C, or
43°C, the mutants eluted at the expected elution volume for the
trimeric form of the protein (Fig. 5A
and
B). In the elution profile of
PDZ2 DegPS210A, a small
peak representing
10% of the total injected protein was
observed at the elution volume expected for a hexamer. Sedimentation
equilibrium experiments were carried out with the
PDZ2
DegPS210A (Table
1) mutant, and a global
data analysis in terms of a single ideal solute showed excellent fit
consistent with the presence of a monodisperse species (Fig.
5C). The analysis returned
a molecular mass of 123 ± 4 kDa (expected monomer mass
= 37,267.3 Da; stoichiometry, n =
3.4 ± 0.1) (Table
2), consistent with the
observation by size exclusion chromatography that this mutant is
exclusively a trimer in solution.
![]() View larger version (37K): [in a new window] |
FIG. 5. PDZ1
and PDZ2 DegP mutants are trimers. (A) Elution
profiles of PDZ1 and PDZ2 DegP mutants and their
proteolytically inactive variants (S210A mutants) after incubation at
4°C for 1 h. The dashed lines in the plot on the
right-hand side indicate the expected elution volume for the hexameric
(12 ml) and the trimeric (13.5 ml) forms of these mutants.
(B) Samples from each peak were resolved by SDS-PAGE (15%
polyacrylamide) and stained with Coomassie brilliant blue. In the gel
for PDZ2 DegPS210A, the middle lane corresponds to
a sample obtained from the peak eluting at 11.6 ml. (C)
Sedimentation equilibrium profiles shown in terms of
A280 versus the radius, r, for the
PDZ2 DegPS210A mutant at a loading
A280 of 0.29. Data were collected at 6 (blue), 8
(green), and 10 (red) krpm at 4.0°C and analyzed in terms of a
single ideal solute. Best fits are shown as black lines through the
experimental points, and the corresponding distributions of the
residuals are shown on the left-hand side of the
plot.
|
PDZ1 DegP suggest that the PDZ1 domain maintains
the integrity of the hexameric cage by allowing the PDZ2 domain to
reach the PDZ1 and PDZ2 domains of a monomer at the opposite end of the
hexamer, rather than establishing interactions with another
monomer. Protease and chaperone activities are observed in DegP mutants without an enclosed cavity. Our finding that both the broken cage and the deleted PDZ domain mutants do not form hexamers gave us the opportunity to test whether the lack of an enclosed cavity prevents DegP from having molecular chaperone and protease activities.
The
chaperone activity of the broken cage DegPS210A mutant was
tested by the in vitro refolding assay, and we found that this mutant
refolded CS with similar efficiency to the DegPS210A mutant
(Fig.
6A). Similarly,
PDZ1 and
PDZ2 DegPS210A mutants
were also able to refold CS
(Fig. 7A),consistent with previous findings
(23).
![]() View larger version (24K): [in a new window] |
FIG. 6. Chaperone
and protease activity of the broken cage DegP mutant. (A)
Refolding of denatured citrate synthase in the absence of proteins or
in the presence of a fourfold molar excess of broken cage
DegPS210A mutant. Citrate synthase activity is expressed as
a percentage of the highest specific activity value observed in the
DegPS210A reaction. (B) Representative proteolysis
plots of the broken cage DegP mutant (solid line) and wild-type (WT)
DegP (dashed line) for MDH, ß-casein, and lysozyme (left
plots). The rates of hydrolysis for each substrate were measured and
normalized to the rate observed for wild-type DegP. Proteolysis
reactions for each substrate were repeated three times, and averages
and standard deviations were calculated (right plot). AU, arbitrary
units; slp,
slope.
|
![]() View larger version (21K): [in a new window] |
FIG. 7. Chaperone
and protease activity of the PDZ DegP mutants. (A)
Four molar excess of either PDZ1 or PDZ2 DegP mutants
was mixed with unfolded citrate synthase under refolding conditions.
Samples were taken at the indicated time points, and the CS specific
activity was determined. Results are expressed as the percentage of the
highest specific activity observed in the refolding reaction performed
in the presence of DegPS210A. DCS, denatured citrate
synthase. MDH (B), ß-casein (C), or lysozyme (D) was
incubated with either
PDZ1 or PDZ2 DegP mutants. Proteolysis plots were
calculated (B, C, and D, left plots) as described. Mutant DegP is shown
by the solid line, and the wild-type (WT) DegP protein is shown by the
dashed line. Averages and standard deviations of the rates were
obtained for each reaction condition (B, C, and D, right plots). AU,
arbitrary units; slp,
slope.
|
PDZ2 DegP mutant was also able to degrade these three
substrates very efficiently. However, the
PDZ1 DegP mutant
showed very little activity (Fig.
7B).
We conclude
from these data that the PDZ2 domain is not required for protease
activity, whereas the PDZ1 domain seems to be sufficient to render a
protease as active as the wild-type DegP protein. However, the presence
of the protease domain and any of the two PDZ domains was sufficient
for DegP to maintain its molecular chaperone activity. As both
PDZ domain mutants were mostly trimers in solution and the
broken cage mutant did not form a hexamer, we conclude that the
presence of an enclosed cavity is not essential for DegP to perform its
protease and molecular chaperone
activities.
|
|
|---|
Due to the sequestration of the active sites, the DegP protein is an example of a self-compartmentalized protease. Access routes to the inner chamber lie between the pillars formed by the LA loops. However, these lateral windows and the inner chamber itself are only big enough to accommodate little more than individual secondary structure elements. In fact, previous unfolding of protein substrates is essential for hydrolysis by DegP (10), which has been interpreted as a suggestion that substrates are channeled into the inner chamber for proteolysis. Unfortunately, there is still no experimental evidence showing that substrates are delivered into the inner chamber for subsequent cleavage or refolding. To clarify the necessity of having an enclosed cavity for protease and molecular chaperone activity, we constructed several DegP deletion mutants having reduced inner cavity dimensions, along with mutants which formed trimers and thus were without the enclosed cavity. Our results demonstrate that neither a cavity of specific dimensions nor the presence of an enclosed cage is required to maintain protease and chaperone activity in DegP. These results are consistent with other trimeric members of the HtrA family, such as mammalian HtrA2 (12), that act as proteases (4, 20).
Interestingly, in the reduced cage DegP mutant, the proteolytic activity increased as we studied smaller substrates, suggesting that the size of the cage becomes less relevant for protease activity as the molecular mass of the substrate decreases. These data support the hypothesis that proteolysis takes place once the substrate has accumulated in the inner chamber. Therefore, reducing its size may decrease proteolysis rates for bigger substrates but not for small ones. In fact, our observation that the trimeric broken cage DegP is proteolytically more active than the wild type is consistent with this hypothesis as the catalytic sites are no longer confined within an enclosed cavity, and thus they are more readily accessible to the substrates.
DegP is a self-compartmentalized protease, and it has been hypothesized that unfolded polypeptides are threaded in an extended conformation into the cage to access the proteolytic sites. The height of the cavity in the collapsed cage mutant is predicted to be significantly smaller than 15 Å, and thus the size of its lateral openings, which grant access of the substrate to the inner chamber, is most likely not large enough to allow the threading of an unfolded protein. It was therefore surprising to observe significant protease activity in this mutant under the hypothesis that unfolded polypeptides are threaded in an extended conformation into the cage to access the proteolytic sites. Thus, these results raise the possibility that substrates may also access the catalytic sites through the transient disassembly of the hexameric cage. Interaction of DegP with a specific substrate may be the initial event promoting the disassembly of the hexamer. In this context, the functional reason for the stable hexameric form of DegP observed in the crystal structure in the absence of substrate would be to prevent indiscriminate substrate proteolysis by sequestering the catalytic sites. Therefore, the described X-ray structure of the DegP hexameric cage constitutes a double-layer safety mechanism protecting the cell from uncontrolled proteolysis, which can be hazardous to the cell. First, the cage physically limits the access of substrates to the catalytic sites, and second, the catalytic triad is in an inactive conformation. DegP interaction with a substrate protein may promote the disassembly of the DegP cage and further stimulate a conformational change that renders the catalytic triad in an active form, in a similar manner to the activation mechanism of another member of this family of proteins, DegS (26, 28).
There are also many similarities between the structure of the hexameric DegP and other well-characterized chaperones, such as GroEL. Both proteins form an enclosed cavity, and the walls of the cavity contain hydrophobic patches used for binding of unfolded proteins. However, there are important fundamental differences between the DegP and GroEL structures. Whereas GroEL has a large opening of about 45 Å through which nascent and unfolded proteins can access the chamber and be released upon reaching a native state, the lateral openings in the DegP hexamer are only 20 Å wide. Therefore, it is unclear how refolded substrates are released from the cage, assuming that substrate folding actually happens inside the chamber. Our data showing that an enclosed cavity is not required for DegP chaperone activity and that DegP mutant with a significantly smaller window size has similar chaperone activity to wild-type DegP suggest that DegP does not require enclosure of its substrates in the inner chamber for refolding as GroEL does. Alternatively, DegP may perform its chaperone activity by binding hydrophobic sequences of unfolded substrates (similarly to DnaK chaperone [8]), upon disassembly of the hexameric cage, which allows substrates to access the hydrophobic surfaces coating the ceilings of the inner chamber. Interestingly, it has been shown that a monomeric polypeptide containing residues 191 to 345 from GroEL has the same activity as the tetradecamer of GroEL in refolding rhodanase in vitro (29). Therefore, in GroEL as well, the presence of a central cavity is not essential for chaperone activity in vitro. However, it could still be important for refolding in vivo and to regulate the affinity of the protein for its various substrates.
A deletion analysis such as the one reported here has the intrinsic problem that the deletion mutants may produce atypical results simply because the deletion mutants either fail to fold correctly or are unstable. However, some of our data in fact indicate that the deletion mutants in this study are properly folded and are stable: (i) the various mutants showed both chaperone and protease activity; (ii) all deletion mutants behaved as expected in terms of their oligomeric size, including after incubation at 43°C for 1 h; and (iii) the collapsed cage DegPS210A and DegPS210A mutant showed S-values which correlate with their mass, indicative of similar overall shape. Furthermore, previous work has shown that PDZ domains are highly modular domains (7) and that it is relatively easy to change the PDZ domain binding specificity by mutations but without compromising the domain structure (25). Moreover, an infrared spectroscopic study has shown that mutational alterations in serine 210 and histidine 105 induced minor changes in the tertiary structure of DegP (22). Finally, with respect to the stability of our trimeric DegP mutants, there are members of the HtrA family of proteins that are functional trimers, as shown by the crystal structure of E. coli DegS (28) and human HtrA2 (12).
In conclusion, our results show that an enclosed cavity is not essential for the protease and chaperone activity of DegP. Future experiments will actually test whether DegP remains as a hexameric cage upon interaction with its substrates and whether DegP works similarly to other self-compartmentalized proteases and chaperones where the substrates are translocated to the inner chamber for hydrolysis or refolding.
This work was supported by grants from the Canadian Institutes of Health Research (CIHR), Canada Foundation for Innovation (CFI), and Ontario Innovation Trust (OIT). J.O. is a recipient of a CIHR salary award. R.G. was supported by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases.
Published ahead of print on 22 November 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»